There is also a possible mechanism of upregulation of MCL-1 expression and downregulation of BCL-2 and BAX expression in some AML cells due to activation of NF-KB pathway and ERK pathway by KRAS mutations (36). This evidence concerns the gene BAX and acute myeloid leukemia.